PGDI Display

Last Updated: June 28, 2020

PGDI Banner

Filtered Data ExportFull Data Export
Project Name Project Country Cancer Type Total Tumor Samples Total Tumor WXS Total Tumor WGS Project PI Primary Project Publication(s)
Individualized Cancer Therapy (iCat) Recommendation for Patients with Relapsed, Refractory, or High-Risk Solid Tumors - Epitheliod Sarcoma USA
Malignant neoplasm of other connective and soft tissue
1 0 0 https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355
Individualized Cancer Therapy (iCat) Recommendation for Patients with Relapsed, Refractory, or High-Risk Solid Tumors - Ewing Sarcoma USA
Malignant neoplasm of bone and articular cartilage of limbs
3 0 0 https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355
Individualized Cancer Therapy (iCat) Recommendation for Patients with Relapsed, Refractory, or High-Risk Solid Tumors - Other NRSTS USA
Malignant neoplasm of other connective and soft tissue
5 0 0 https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355
Individualized Cancer Therapy (iCat) Recommendation for Patients with Relapsed, Refractory, or High-Risk Solid Tumors - Rare Tumors USA
Malignant neoplasm of other and ill-defined sites
8 0 0 https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355
Individualized Cancer Therapy (iCat) Recommendation for Patients with Relapsed, Refractory, or High-Risk Solid Tumors - Synovial Sarcoma USA
Malignant neoplasm of other connective and soft tissue
6 0 0 https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355
Individualized Cancer Therapy (iCat) Recommendation for Patients with Relapsed, Refractory, or High-Risk Solid Tumors - Undifferentiated Sarcoma USA
Malignant neoplasm of other and ill-defined sites
8 0 0 https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355
Individualized Cancer Therapy (iCat) Recommendation for Patients with Relapsed, Refractory, or High-Risk Solid Tumors - Wilms Tumor USA
Malignant neoplasm of the Kidney
7 0 0 https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355
Individualized Cancer Therapy (iCat) Recommendation for Patients with Relapsed, Refractory, or High-Risk Solid Tumors – Neuroblastoma USA
Malignant neoplasm of adrenal gland
7 0 0 https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355
Individualized Cancer Therapy (iCat) Recommendation for Patients with Relapsed, Refractory, or High-Risk Solid Tumors – Osteosarcoma USA
Malignant neoplasm of bone and articular cartilage of limbs
4 0 0 https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355
Individualized Cancer Therapy (iCat) Recommendation for Patients with Relapsed, Refractory, or High-Risk Solid Tumors – Rhabdomyosarcoma USA
Malignant neoplasm of other connective and soft tissue
8 0 0 https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355
International Cancer Genome Consortium (ICGC) Pediatric Brain Tumor (PedBrain) Medulloblastoma (MB) Germany
Malignant neoplasm of brain
241 239
Stefan M. Pfister
https://www.ncbi.nlm.nih.gov/pubmed/28726821
International Cancer Genome Consortium (ICGC) Pediatric Brain Tumor (PedBrain) Pediatric Glioblastoma Germany
Malignant neoplasm of brain
53 53
Stefan M. Pfister
https://pubmed.ncbi.nlm.nih.gov/27748748/
International Cancer Genome Consortium (ICGC) Pediatric Brain Tumor (PedBrain) Pilocytic Astrocytoma Germany
Malignant neoplasm of brain
96 96
Stefan M. Pfister
https://pubmed.ncbi.nlm.nih.gov/23817572/
International Neuroblastoma Risk Group (INGR) *USA, Australia, Germany, Japan, Austria, Belgium, The Czech Republic, Denmark, France, Hungary, Israel, Italy, Norway, Poland, Portugal, Spain, Sweden, Switzerland, The United Kingdom, Greece
Malignant neoplasm of peripheral nerves and autonomic nervous system
Malignant neoplasm of adrenal gland
Sam Volchenboum
https://www.ncbi.nlm.nih.gov/pubmed/19047291
International Soft Tissue Sarcoma Consortium (INSTRuCT) *USA, Italy, France, UK, The Netherlands, Spain, Belgium, Ireland, Denmark, Norway, Czech Republic, Slovenia, Israel, Argentina, Brazil, Australia, Germany
Malignant neoplasm of other connective and soft tissue
Sam Volchenboum
Pediatric Cancer Genome Project (PCGP) - Acute Lymphoblastic Leukemia (ALL)
Lymphoid leukemia
76 51 25
Charles G. Mullighan
Stephen P. Hunger
Jinghui Zhang
https://www.ncbi.nlm.nih.gov/pubmed/25790293
Pediatric Cancer Genome Project (PCGP) - Adrenocortical Tumor (ACT)
Malignant neoplasm of adrenal gland
38 18 8
Gerard P. Zambetti
Raul C. Ribbeiro
Jinghui Zhang
https://www.ncbi.nlm.nih.gov/pubmed/25743702
Pediatric Cancer Genome Project (PCGP) - AMLM7
Other leukemias of specified cell type
19 19 4
James R Downing
https://www.ncbi.nlm.nih.gov/pubmed/23153540
Pediatric Cancer Genome Project (PCGP) - ATRX
92 44 48
Pediatric Cancer Genome Project (PCGP) - BALL-PAX5
135 3 0
Pediatric Cancer Genome Project (PCGP) - Core-Binding Factor (CBF) Acute Myeloid Leukemia
Myeloid leukemia
183 166 17 https://www.ncbi.nlm.nih.gov/pubmed/27798625
Pediatric Cancer Genome Project (PCGP) - CPC
4 0 4
Pediatric Cancer Genome Project (PCGP) - E2A
53 29 33
Pediatric Cancer Genome Project (PCGP) - Ependymoma (EPD)
Neoplasm of uncertain behavior of brain and central nervous system
77 25 40
Richard J. Gilbertson
David W. Ellison
Jinghui Zhang
https://www.ncbi.nlm.nih.gov/pubmed/24553141
Pediatric Cancer Genome Project (PCGP) - ERG
Lymphoid leukemia
39 21 22
Charles G. Mullighan
Jinghui Zhang
https://www.ncbi.nlm.nih.gov/pubmed/27776115
Pediatric Cancer Genome Project (PCGP) - ERG2
53 0 0
Pediatric Cancer Genome Project (PCGP) - ETV
53 6 50
Pediatric Cancer Genome Project (PCGP) - EWS
Malignant neoplasm of bone and articular cartilage of other and unspecified sites
46 11 35
Oliver Delattre
Jinghui Zhang
https://www.ncbi.nlm.nih.gov/pubmed/25223734
Pediatric Cancer Genome Project (PCGP) - High Grade Glioblastoma (HGG)
Malignant neoplasm of brain
70 43 22
Suzanne J. Baker
Jinghui Zhang
James R. Downing
Richard K. Wilson
https://www.ncbi.nlm.nih.gov/pubmed/24705251, https://www.ncbi.nlm.nih.gov/pubmed/22286216
Pediatric Cancer Genome Project (PCGP) - Histone
467 0 0
Suzanne J. Baker
Jinghui Zhang
James R. Downing
Richard K. Wilson
https://www.ncbi.nlm.nih.gov/pubmed/24710217, https://www.ncbi.nlm.nih.gov/pubmed/22286216
Pediatric Cancer Genome Project (PCGP) - HYPER
62 37 45
Pediatric Cancer Genome Project (PCGP) - Hypodiploid Acute Lymphoblastic Leukemia (HYPO)
Lymphoid leukemia
33 14 20
Charles G. Mullighan
https://www.ncbi.nlm.nih.gov/pubmed/23334668
Pediatric Cancer Genome Project (PCGP) - Infant Acute Lymphoblastic Leukemia (INF)
Lymphoid leukemia
66 26 25
Anna K. Andersson
Tanja A. Gruber
James R. Downing
https://www.ncbi.nlm.nih.gov/pubmed/25730765
Pediatric Cancer Genome Project (PCGP) - Low Grade Glioma (LGG)
Malignant neoplasm of brain
8 0 0
David W Ellison
https://www.ncbi.nlm.nih.gov/pubmed/23583981, https://www.ncbi.nlm.nih.gov/pubmed/26810070
Pediatric Cancer Genome Project (PCGP) - Medulloblastoma (MB)
Malignant neoplasm of brain
38 0 38
Richard J. Gilbertson
Jinghui Zhang
James R. Downing
Richard K. Wilson
https://www.ncbi.nlm.nih.gov/pubmed/22722829, https://www.ncbi.nlm.nih.gov/pubmed/26199091
Pediatric Cancer Genome Project (PCGP) - Melanoma (MEL)
Malignant melanoma of skin
18 14 5 https://www.ncbi.nlm.nih.gov/pubmed/25268584
Pediatric Cancer Genome Project (PCGP) - Osteosarcoma (OS)
Malignant neoplasm of bone and articular cartilage of other and unspecified sites
34 0 34
Michael A. Dyer
Jinghui Zhang
https://www.ncbi.nlm.nih.gov/pubmed/24703847
Pediatric Cancer Genome Project (PCGP) - Ph-like Acute Lymphoblastic Leukemia (Ph-like ALL)
Lymphoid leukemia
136 12 40
Charles G. Mullighan
https://www.ncbi.nlm.nih.gov/pubmed/25207766, https://www.ncbi.nlm.nih.gov/pubmed/26102509
Pediatric Cancer Genome Project (PCGP) - PHALL
40 18 37
Pediatric Cancer Genome Project (PCGP) - Retinoblastoma (RB)
Malignant neoplasm of eye and adnexa
14 0 14
Michael A. Dyer
James R. Downing
Richard K. Wilson
https://www.ncbi.nlm.nih.gov/pubmed/22237022, https://www.ncbi.nlm.nih.gov/pubmed/21840489
Pediatric Cancer Genome Project (PCGP) - Rhabdomyosarcoma (RHB)
Malignant neoplasm of other connective and soft tissue
39 21 13
Michael A Dyer
https://www.ncbi.nlm.nih.gov/pubmed/24332040
Pediatric Cancer Genome Project (PCGP) - T-cell Acute Lymphoblastic Leukemia (TALL)
Lymphoid leukemia
29 16 13
James R. Downing
Charles G. Mullighan
https://www.ncbi.nlm.nih.gov/pubmed/22237106, https://www.ncbi.nlm.nih.gov/pubmed/21666668
The Genomic Landscape of Tuberous Sclerosis Complex (TSC) USA
Malignant neoplasm of brain
Malignant neoplasm of kidney, except renal pelvis
Malignant neoplasm of heart, mediastinum and pleura
Other and unspecified malignant neoplasm of skin
62 61 0
Jeffrey P. MacKeigan
https://www.ncbi.nlm.nih.gov/pubmed/28643795
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) - Clear Cell Sarcoma of the Kidney (CCSK) USA
Malignant neuroendocrine tumors
Elizabeth J. Perlman
https://pubmed.ncbi.nlm.nih.gov/26158413/
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) - Osteosarcoma (OS) Brazil, Canada, Japan, USA
Malignant neoplasm of bone and articular cartilage of other and unspecified sites
Ching Lau
Paul M. Meltzer
In Progress
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) - Phase I Acute Lymphoblastic Leukemia (ALL) USA
Lymphoid leukemia
136 12 40
Stephen P. Hunger
Charles G. Mullighan
Cheryl Willman
https://pubmed.ncbi.nlm.nih.gov/19129520/
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) - Phase II Acute Lymphoblastic Leukemia (ALL) USA
Lymphoid leukemia
29 16 13
Stephen P. Hunger
Mignon Loh
Charles G. Mullighan
In Progress
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) - Rhabdoid Tumor (RT) USA
Malignant neuroendocrine tumors
Elizabeth J. Perlman
https://pubmed.ncbi.nlm.nih.gov/26977886/
Therapeutically Applicable Research to Generate Effective Treatments (TARGET) - Wilms Tumor (WT) USA
Malignant neoplasm of adrenal gland
Elizabeth J. Perlman
Submitted